SEOM clinical guideline in ovarian cancer (2020)
Clin. transl. oncol. (Print)
; 23(5): 961-968, mayo 2021. tab
Article
em En
| IBECS
| ID: ibc-221236
Biblioteca responsável:
ES1.1
Localização: ES15.1 - BNCS
ABSTRACT
Despite remarkable advances in the knowledge of molecular biology and treatment, ovarian cancer remains the leading cause of death from gynecologic cancer. In the last decade, there have been important advances both in systemic and surgical treatment. However, there is no doubt that the incorporation of PARP inhibitors as maintenance after the response to platinum-based chemotherapy, first in recurrent disease and recently also in first line, will change the natural history of the disease. The objective of this guide is to summarize the current evidence for the diagnosis, treatment, and follow-up of ovarian cancer, and to provide evidence-based recommendations for clinical practice (AU)
Palavras-chave
Texto completo:
1
Coleções:
06-national
/
ES
Base de dados:
IBECS
Assunto principal:
Neoplasias Ovarianas
Limite:
Female
/
Humans
País/Região como assunto:
Europa
Idioma:
En
Revista:
Clin. transl. oncol. (Print)
Ano de publicação:
2021
Tipo de documento:
Article